We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SVRA market cap is 598.32M. The company's latest EPS is USD -0.3323 and P/E is -10.95.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.22M | -18.04M | -17.63M | -22.48M | -23.19M |
Net Income | -11.44M | -16.6M | -16.1M | -20.35M | -22.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 257k | 0 | 0 | 0 |
Operating Income | -79.03M | -49.3M | -41.48M | -38.84M | -60.01M |
Net Income | -78.17M | -49.62M | -43.01M | -38.15M | -54.7M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 119.83M | 182.07M | 177.56M | 158.3M | 139.67M |
Total Liabilities | 32.12M | 35.53M | 37.19M | 36.43M | 37.94M |
Total Equity | 87.72M | 146.54M | 140.37M | 121.86M | 101.73M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 136.2M | 97.75M | 176.6M | 139.78M | 177.56M |
Total Liabilities | 34.51M | 33.36M | 32.1M | 32M | 37.19M |
Total Equity | 101.7M | 64.38M | 144.5M | 107.78M | 140.37M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -22.3M | -35.46M | -51.06M | -20.64M | -43.14M |
Investing | -7.1M | -63.69M | -57.12M | 10.79M | 40.33M |
Financing | 130k | 74.89M | 82.78M | 49k | 104k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -45.12M | -39.84M | -40.08M | -34.55M | -51.06M |
Investing | 15.74M | 9.05M | -69.46M | 52.65M | -57.12M |
Financing | 54.91M | 3.69M | 120.81M | 87k | 82.78M |
Market Cap | 598.32M |
Price to Earnings Ratio | -10.95 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 22.54 |
Price to Book Ratio | 4.27 |
Dividend Yield | - |
Shares Outstanding | 164.6M |
Average Volume (1 week) | 1.63M |
Average Volume (1 Month) | 999.06k |
52 Week Change | -0.41% |
52 Week High | 5.70 |
52 Week Low | 3.115 |
Spread (Intraday) | 0.06 (1.64%) |
Company Name | Savara Inc |
Address |
corporation service company wilmington, delaware 19808 |
Website | https://savarapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions